PREPARATION AND CHARACTERIZATION OF SOLID DISPERSION LOADED WITH SELEXIPAG AS MODEL DRUG
Open Access
- 23 December 2025
- journal article
- Published by Innovare Academic Sciences Pvt Ltd in International Journal of Applied Pharmaceutics
Abstract
Objective: The study aims to prepare solid dispersions of selexipag to enhance its aqueous solubility using two different techniques—solvent evaporation and kneading. Methods: Twenty-seven solid dispersion (SD) formulations of selexipag were prepared using two different techniques, solvent evaporation (SE) and kneading (KN). Various hydrophilic carriers were employed, including urea, polyethylene glycol 4000 (PEG 4000), polyethylene glycol 6000 (PEG 6000), poloxamer 188 (PXM 188), and poloxamer 407 (PXM 407), at drug-to-polymer ratios of 1:1, 1:3, and 1:5. The prepared formulations were evaluated for saturation solubility, drug content, percentage yield, and in vitro dissolution. Fourier transform infrared spectroscopy (FTIR) was performed to assess drug-polymer compatibility. Results: The saturation solubility was enhanced by all prepared solid dispersion formulations. The pure selexipag exhibited a solubility of 1.5 ± 0.04 µg/ml, whereas the optimized formulation (F2, PXM407:Selexipag 3:1) prepared by the solvent evaporation method showed a solubility of 25.9 ± 0.2 µg/ml, representing approximately a 17-fold increase compared to the pure drug. The optimized formulation also demonstrated a faster dissolution rate, with 88% of the drug released within 30 min. FTIR results further confirmed drug-carrier compatibility; no additional peaks were observed in any of the binary systems, indicating the absence of chemical interaction between selexipag and the polymer. Conclusion: Solid dispersion, particularly using poloxamer 407 via solvent evaporation, proved to be an effective and promising approach for enhancing the solubility, dissolution rate, and overall biopharmaceutical performance of selexipag.Keywords
This publication has 34 references indexed in Scilit:
- Pharmaceutical approaches for enhancing solubility and oral bioavailability of poorly soluble drugsEuropean Journal of Pharmaceutics and Biopharmaceutics, 2024
- Design of mirtazapine solid dispersion with different carriers’ systems: optimization, in vitro evaluation, and bioavailability assessmentDrug Delivery and Translational Research, 2023
- Improving solubility of poorly water-soluble drugs by protein-based strategy: A reviewInternational Journal of Pharmaceutics, 2023
- Pharmaceutical amorphous solid dispersion: A review of manufacturing strategiesActa Pharmaceutica Sinica B, 2021
- Enhanced dissolution of solid dispersions containing bicalutamide subjected to mechanical stressInternational Journal of Pharmaceutics, 2018
- Selexipag: A Review in Pulmonary Arterial HypertensionAmerican Journal of Cardiovascular Drugs, 2016
- Development of a Solid Dispersion System for Improving the Oral Bioavailability of Resveratrol in RatsEuropean Journal of Drug Metabolism and Pharmacokinetics, 2016
- Solid dispersions containing ursolic acid in Poloxamer 407 and PEG 6000: A comparative study of fusion and solvent methodsPowder Technology, 2014
- Solubility enhancement of desloratadine by solid dispersion in poloxamersInternational Journal of Pharmaceutics, 2012
- Sustained release of lidocaine from Poloxamer 407 gelsInternational Journal of Pharmaceutics, 2005